GO
Loading...

California

More

  • LIMA, Peru— Indigenous communities that sued Occidental Petroleum over contamination in Peru's northern Amazon have reached an out-of-court settlement in which the California- based oil company will pay them an undisclosed sum. The case was the first of its kind involving oil drilling in South America to advance in U.S. courts, said attorney Marco Simons of...

  • The American Pet Products Association's annual report on pet industry spending says Americans spent $58 billion in 2014 on their 397 million pets, which range from freshwater fish and reptiles to cats and dogs. Last year, people spent $22 billion on food; $15 billion on veterinary care; $14 billion on supplies such as beds, bowls and collars and over-the-counter...

  • WELLESLEY, Mass.— Wellesley College is joining a growing list of women's colleges that accept transgender students. President H. Kim Bottomly and trustees' chairwoman Laura Daignault Gates said in a letter Wednesday that " Wellesley will consider for admission any applicant who lives as a woman and consistently identifies as a woman." Mount Holyoke and Simmons...

  • NEW HAVEN, Conn.— A requirement that Yale undergraduates on financial aid pay up to $6,400 annually toward their education is coming under protest from students who argue it creates a divide along class lines and keeps them from participating more in campus life. University spokeswoman Karen Peart said Yale, like all schools, "expects students to make a modest...

  • The FDA confirmed that Olympus Corp. did not seek FDA clearance for the latest version of its specialized endoscope, which it began selling in 2010. FDA clearance is required for all substantive updates to medical devices sold in the U.S. Despite the lack of clearance, the FDA said doctors should continue using the device because it's not clear that a federal...

  • MIAMI, March 5- A $5 million class-action lawsuit filed this week in Florida accuses hardwood and laminate flooring giant Lumber Liquidators, Inc of selling products laden with cancer-causing chemicals. Senator Bill Nelson of Florida, the ranking Democrat on the Senate Committee on Commerce, Science and Transportation, called on federal agencies Wednesday...

  • Avalanche Biotech reports 4Q loss Thursday, 5 Mar 2015 | 10:10 AM ET

    MENLO PARK, Calif. _ Avalanche Biotechnologies Inc. on Thursday reported a loss of $10.4 million in its fourth quarter. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share. This story was generated by Automated Insights using data from Zacks Investment Research.

  • March 5- Kroger Co, the biggest U.S. supermarket operator, forecast a full-year profit above analysts' estimates as it benefits from its acquisition of Harris Teeter Supermarkets Inc and higher margins on fuel. Kroger shares rose 6.7 percent to a record high of $74.30 in morning trading on Thursday. Kroger completed its $2.5 billion acquisition of Harris Teeter...

  • Supermarket operator Kroger's profit rises 23 pct Thursday, 5 Mar 2015 | 8:53 AM ET

    March 5- Kroger Co, the biggest U.S. supermarket operator, on Thursday reported a 23 percent rise in quarterly profit, helped by its acquisition of Harris Teeter Supermarkets Inc and higher margins on fuel. Net income attributable to Kroger rose to $518 million, or $1.04 per share, in the fourth quarter ended Jan. 31, from $422 million, or 81 cents per share, a year...

  • Ares Management misses 4Q profit forecasts Thursday, 5 Mar 2015 | 8:33 AM ET

    LOS ANGELES _ Ares Management LP on Thursday reported fourth-quarter profit of $3.2 million. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of 36 cents per share. Ares Management shares have increased 19 percent since the beginning of the year.

  • POLK CITY, Fla.— The Ringling Bros. and Barnum& Bailey Circus will phase out the show's iconic elephants from its performances by 2018, telling The Associated Press exclusively that growing public concern about how the animals are treated led to the decision. Executives from Feld Entertainment, Ringling's parent company, said the decision to end the circus's...

  • Arrowhead buys Novartis' RNAi portfolio Thursday, 5 Mar 2015 | 7:34 AM ET

    March 5- Arrowhead Research Corp said it acquired Novartis AG's RNAi assets to fortify its position in the field of gene therapy that aims to wipe out disease-causing proteins. Novartis is eligible to receive $25 million in Arrowhead shares within 30 days, which would make it the second-largest shareholder based on Arrowhead's market value on Wednesday.

  • NEW YORK, March 5- Exchange-traded funds designed to let investors play China's bond markets, which are mostly closed to foreigners, are facing a slow start amid concerns about mainland issuers' credit quality, high property prices and the slowing economy. At more than $5 trillion, China's onshore fixed-income markets are outranked only by the U.S. and Japanese...

  • Dynavax Technologies reports 4Q loss Thursday, 5 Mar 2015 | 6:48 AM ET

    BERKELEY, Calif. _ Dynavax Technologies Corp. on Thursday reported a loss of $22.3 million in its fourth quarter. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share. Dynavax Technologies shares have climbed 26 percent since the beginning of the year.

  • BEIJING, March 5- China's transport minister said on Thursday he hopes to have regulations issued on using mobile apps to book private cars within the first half of 2015, state media reported, amid doubts on the legal status in China of Uber and similar services. In January, China's Ministry of Transport banned taxi hailing apps such as Uber Technologies Inc and...

  • SAN FRANCISCO— The woman at the center of a sex discrimination lawsuit against one of Silicon Valley's most prestigious venture capital firms is set to take the stand in a case that has focused attention on the treatment of women in the high-tech and venture capital fields. Ellen Pao says she was passed over for a promotion at Kleiner Perkins Caufield& Byers...

  • March 5- AbbVie Inc is to buy Pharmacyclics Inc for about $21 billion, giving it access to what is expected to be one of the world's top-selling cancer drugs and expanding its reach in the profitable oncology field. AbbVie will pay $261.25 per share in cash and stock, a 13 percent premium to Pharmacyclics stock's closing price on Wednesday. Deutsche Bank analyst...

  • *AbbVie to pay $261.25 per share in cash and stock. The deal gives AbbVie access to Pharmacyclics' cancer drugs portfolio, lessening the Chicago- based company's dependence on its rheumatoid arthritis drug Humira that accounts for most of its sales. "Imbruvica is not only complementary to AbbVie's oncology pipeline, it has demonstrated strong clinical...

  • AbbVie will spend about $21 billion to buy fellow drugmaker Pharmacyclics and add another major revenue producer to a portfolio that already includes the world's top-selling drug. AbbVie executives told analysts on Thursday that their company could reap more than $7 million in annual sales from Imbruvica in a few years. While AbbVie touted the potential...

  • LOS ANGELES, March 4- A second top Los Angeles hospital has reported an outbreak of drug-resistant "superbug" infections, and dozens more potential exposures, from procedures performed with a fiber-optic instrument called a duodenoscope. The Cedars-Sinai cases, like the larger number of infections and potential exposures reported last month at the UCLA...